{"id":"https://openalex.org/W2093689408","doi":"https://doi.org/10.2165/11591240-000000000-00000","title":"Axitinib for the Management of Metastatic Renal Cell Carcinoma","display_name":"Axitinib for the Management of Metastatic Renal Cell Carcinoma","alternate_titles":[],"publication_year":2011,"publication_date":"2011-06-01","ids":{"openalex":"https://openalex.org/W2093689408","doi":"https://doi.org/10.2165/11591240-000000000-00000","mag":"2093689408","pmid":"https://pubmed.ncbi.nlm.nih.gov/21679004","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3585900"},"language":"en","primary_location":{"id":"doi:10.2165/11591240-000000000-00000","doi":"https://doi.org/10.2165/11591240-000000000-00000","is_oa":true,"landing_page_url":"https://doi.org/10.2165/11591240-000000000-00000","pdf_url":"https://link.springer.com/content/pdf/10.2165/11591240-000000000-00000.pdf","source":{"id":"https://openalex.org/S35266406","display_name":"Drugs in R&D","issn_l":"1174-5886","issn":["1174-5886","1179-6901"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","medline","norway-1","oarl","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs in R&amp;D","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2093689408"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://link.springer.com/content/pdf/10.2165/11591240-000000000-00000.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049672639","display_name":"Bernard J. Escudier","orcid":"https://orcid.org/0000-0002-4626-0479","observed_orcids":["https://orcid.org/0000-0002-4626-0479"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Bernard Escudier","raw_affiliation_strings":["Institut Gustave Roussy, 114 rue Edouard Vaillant, 94805, Villejuif, France","Institut gustave Roussy, Villejuif, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Gustave Roussy, 114 rue Edouard Vaillant, 94805, Villejuif, France","institution_ids":["https://openalex.org/I2801843802"]},{"raw_affiliation_string":"Institut gustave Roussy, Villejuif, France;","institution_ids":["https://openalex.org/I2801843802"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113897043","display_name":"Martin Eric Gore","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Martin Gore","raw_affiliation_strings":["Institute of Cancer Research, Royal Marsden Hospital, London, UK","Royal Marsden Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Cancer Research, Royal Marsden Hospital, London, UK","institution_ids":["https://openalex.org/I142947616","https://openalex.org/I4210121186"]},{"raw_affiliation_string":"Royal Marsden Hospital","institution_ids":["https://openalex.org/I4210121186"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5049672639"],"corresponding_institution_ids":["https://openalex.org/I2801843802"],"apc_list":{"value":3490,"currency":"USD","value_usd":3490},"apc_paid":{"value":3490,"currency":"USD","value_usd":3490},"fwci":0.9008,"has_fulltext":true,"cited_by_count":165,"citation_normalized_percentile":{"value":0.70408553,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"11","issue":"2","first_page":"113","last_page":"126"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/axitinib","display_name":"axitinib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/metastatic-renal-cell-carcinoma","display_name":"metastatic renal cell carcinoma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.8690000176429749},{"id":"https://openalex.org/keywords/vegfr-inhibition","display_name":"VEGFR inhibition","score":0.8539999723434448},{"id":"https://openalex.org/keywords/angiogenesis-inhibition","display_name":"angiogenesis inhibition","score":0.8790000081062317},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9509999752044678},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.5979999899864197},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.6330000162124634},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7450000047683716},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7329999804496765},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.6190000176429749},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.3199999928474426}],"concepts":[{"id":"https://openalex.org/C2776539811","wikidata":"https://www.wikidata.org/wiki/Q4830631","display_name":"Axitinib","level":4,"score":0.9758152365684509},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6990933418273926},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6916038990020752},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6795349717140198},{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.6286300420761108},{"id":"https://openalex.org/C2777472916","wikidata":"https://www.wikidata.org/wiki/Q1164529","display_name":"Renal cell carcinoma","level":2,"score":0.5417007803916931},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.5356096625328064},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3161102533340454},{"id":"https://openalex.org/C2779490328","wikidata":"https://www.wikidata.org/wiki/Q417542","display_name":"Sunitinib","level":3,"score":0.22276350855827332},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.22095811367034912},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.12468042969703674}],"mesh":[{"descriptor_ui":"D000077784","descriptor_name":"Axitinib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002292","descriptor_name":"Carcinoma, Renal Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002292","descriptor_name":"Carcinoma, Renal Cell","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":true},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007191","descriptor_name":"Indazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007191","descriptor_name":"Indazoles","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D007191","descriptor_name":"Indazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007191","descriptor_name":"Indazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.2165/11591240-000000000-00000","doi":"https://doi.org/10.2165/11591240-000000000-00000","is_oa":true,"landing_page_url":"https://doi.org/10.2165/11591240-000000000-00000","pdf_url":"https://link.springer.com/content/pdf/10.2165/11591240-000000000-00000.pdf","source":{"id":"https://openalex.org/S35266406","display_name":"Drugs in R&D","issn_l":"1174-5886","issn":["1174-5886","1179-6901"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","medline","norway-1","oarl","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs in R&amp;D","raw_type":"journal-article"},{"id":"doi:10.1007/bf03259801","doi":"https://doi.org/10.1007/bf03259801","is_oa":true,"landing_page_url":"https://doi.org/10.1007/bf03259801","pdf_url":"https://link.springer.com/content/pdf/10.2165%2F11591240-000000000-00000.pdf","source":{"id":"https://openalex.org/S35266406","display_name":"Drugs in R&D","issn_l":"1174-5886","issn":["1174-5886","1179-6901"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","medline","norway-1","oarl","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs in R &amp; D","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2590405","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3585900","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3585900","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3585900/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs R D","raw_type":"Text"},{"id":"pmid:21679004","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21679004","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs in R&D","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.2165/11591240-000000000-00000","doi":"https://doi.org/10.2165/11591240-000000000-00000","is_oa":true,"landing_page_url":"https://doi.org/10.2165/11591240-000000000-00000","pdf_url":"https://link.springer.com/content/pdf/10.2165/11591240-000000000-00000.pdf","source":{"id":"https://openalex.org/S35266406","display_name":"Drugs in R&D","issn_l":"1174-5886","issn":["1174-5886","1179-6901"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","medline","norway-1","oarl","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs in R&amp;D","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320319990","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2093689408.pdf","grobid_xml":"https://content.openalex.org/works/W2093689408.grobid-xml"},"referenced_works_count":61,"referenced_works":["https://openalex.org/W922724308","https://openalex.org/W1222874231","https://openalex.org/W1497429764","https://openalex.org/W1666874820","https://openalex.org/W1677048588","https://openalex.org/W1880480189","https://openalex.org/W1966055645","https://openalex.org/W1980013575","https://openalex.org/W1981989535","https://openalex.org/W1999130958","https://openalex.org/W1999966467","https://openalex.org/W2000292756","https://openalex.org/W2010528515","https://openalex.org/W2010848226","https://openalex.org/W2012063336","https://openalex.org/W2013692456","https://openalex.org/W2015042023","https://openalex.org/W2020830322","https://openalex.org/W2028314225","https://openalex.org/W2030709723","https://openalex.org/W2048829586","https://openalex.org/W2071378220","https://openalex.org/W2073749087","https://openalex.org/W2085919694","https://openalex.org/W2096514095","https://openalex.org/W2098136315","https://openalex.org/W2099022883","https://openalex.org/W2099088585","https://openalex.org/W2100569171","https://openalex.org/W2100669312","https://openalex.org/W2104311705","https://openalex.org/W2106787323","https://openalex.org/W2106932520","https://openalex.org/W2111870457","https://openalex.org/W2118677643","https://openalex.org/W2120220319","https://openalex.org/W2122994164","https://openalex.org/W2123769946","https://openalex.org/W2124186186","https://openalex.org/W2130105793","https://openalex.org/W2139248078","https://openalex.org/W2140765540","https://openalex.org/W2143782771","https://openalex.org/W2144390074","https://openalex.org/W2149456801","https://openalex.org/W2152190103","https://openalex.org/W2153331460","https://openalex.org/W2153867442","https://openalex.org/W2162424705","https://openalex.org/W2166573361","https://openalex.org/W2171469612","https://openalex.org/W2198308217","https://openalex.org/W2249990958","https://openalex.org/W2280971710","https://openalex.org/W2334694951","https://openalex.org/W2414641360","https://openalex.org/W2589250791","https://openalex.org/W2768600953","https://openalex.org/W2944460938","https://openalex.org/W3144462267","https://openalex.org/W3151241602"],"related_works":["https://openalex.org/W2017132284","https://openalex.org/W2164011788","https://openalex.org/W2032984534","https://openalex.org/W164470600","https://openalex.org/W2114991862","https://openalex.org/W1999840491","https://openalex.org/W2216545675","https://openalex.org/W2362419704","https://openalex.org/W1973011217"],"abstract_inverted_index":{"In":[0,76,89,175,201,231,279,346],"recent":[1],"years,":[2],"targeted":[3,23,218],"agents":[4,24,40],"have":[5,161],"changed":[6],"the":[7,29,98,123,126,136,142,181,266,280,322,347,350,375,382,391,432,441,452,457],"treatment":[8,20,30,459],"landscape":[9],"for":[10,28],"patients":[11,208,236,284,327,437],"with":[12,95,131,168,191,209,214,225,237,285,328,369,438],"advanced":[13,210],"renal":[14],"cell":[15],"carcinoma":[16],"(RCC),":[17],"greatly":[18],"improving":[19],"outcomes.":[21],"Several":[22],"are":[25,41,428],"now":[26],"licensed":[27],"of":[31,38,101,135,146,183,234,245,283,311,334,339,377,434,454],"metastatic":[32],"RCC":[33,211],"(mRCC),":[34],"and":[35,69,87,157,170,199,265,307,336,362,379,407,443],"a":[36,45,162,226,308,414],"number":[37],"new":[39],"under":[42],"investigation.":[43,421],"Axitinib,":[44],"small":[46],"molecule":[47],"indazole":[48],"derivative":[49],"is":[50,109,119,173,189],"an":[51,240,332],"oral,":[52],"potent":[53],"multitargeted":[54],"tyrosine":[55],"kinase":[56],"receptor":[57],"inhibitor,":[58],"which":[59,365],"selectively":[60],"inhibits":[61],"vascular":[62],"endothelial":[63],"growth":[64],"factor":[65],"receptors":[66],"(VEGFR)-1,":[67],"-2,":[68],"-3":[70],"at":[71,97],"subnanomolar":[72],"concentrations,":[73],"in":[74,83,122,141,207,325,381,390,394,436,440,456],"vitro.":[75],"various":[77],"nonclinical":[78],"models,":[79],"axitinib":[80,92,147,184,187,220,435,455],"has":[81,221],"demonstrated":[82,222],"vivo":[84],"target":[85],"modulation":[86],"antiangiogenesis.":[88],"pharmacokinetic":[90],"studies,":[91,349],"administered":[93,137],"orally":[94],"food":[96],"proposed":[99],"regimen":[100],"5":[102],"mg":[103],"twice":[104],"daily":[105,107],"continuous":[106],"dosing,":[108],"rapidly":[110],"absorbed,":[111],"reaching":[112],"peak":[113],"concentrations":[114],"within":[115],"2-6":[116],"hours.":[117],"Axitinib":[118],"metabolized":[120],"primarily":[121],"liver":[124],"via":[125],"cytochrome":[127],"P450":[128],"(CYP)":[129],"system":[130],"less":[132],"than":[133,387],"1%":[134],"drug":[138],"passing":[139],"unchanged":[140],"urine.":[143],"The":[144,253,295],"pharmacokinetics":[145],"do":[148,159],"not":[149,160,277],"appear":[150],"to":[151,256,430,450],"be":[152],"altered":[153],"by":[154,195],"coadministered":[155],"chemotherapies,":[156],"antacids":[158],"clinically":[163],"significant":[164],"effect.":[165],"However,":[166,417],"coadministration":[167],"CYP3A4":[169],"1A2":[171],"inducers":[172],"contraindicated.":[174],"addition,":[176],"proton":[177],"pump":[178],"inhibitors":[179],"reduce":[180],"rate":[182,243],"absorption.":[185],"Increased":[186],"exposure":[188],"associated":[190],"higher":[192,386],"efficacy":[193,409,433],"indicated":[194],"decreased":[196],"tumor":[197],"perfusion":[198],"volume.":[200],"three":[202,348],"phase":[203,424],"II":[204],"clinical":[205,426],"trials":[206,427],"previously":[212],"treated":[213],"cytokines,":[215],"chemotherapy":[216],"or":[217],"agents,":[219],"antitumor":[223],"activity":[224],"favorable":[227],"non-cumulative":[228],"toxicity":[229],"profile.":[230],"one":[232],"study":[233,282,324,384,393],"Western":[235,392],"cytokine-refractory":[238,329,395],"mRCC,":[239,287],"objective":[241],"response":[242],"(ORR)":[244],"44.2%":[246],"(95%":[247,261,274,291,303,314,342],"CI":[248,262,275,292,304,315,343],"30.5,":[249],"58.7)":[250],"was":[251,258,271,289,300,318,385],"achieved.":[252,319],"median":[254,267,296,309,337],"time":[255],"progression":[257],"15.7":[259],"months":[260,273,302,313,341],"8.4,":[263,316],"23.4)":[264],"overall":[268],"survival":[269,298],"(OS)":[270],"29.9":[272],"20.3,":[276],"estimable).":[278],"second":[281],"sorafenib-refractory":[286],"ORR":[288,333],"22.6%":[290],"12.9,":[293],"35.0).":[294],"progression-free":[297],"(PFS)":[299],"7.4":[301],"6.7,":[305],"11.0)":[306],"OS":[310],"13.6":[312],"18.8)":[317],"Results":[320],"from":[321],"third":[323],"Japanese":[326,383],"mRCC":[330,396,439,458],"reported":[331,355,389],"55%":[335],"PFS":[338],"12.9":[340],"9.8,":[344],"15.6).":[345],"most":[351],"common":[352],"adverse":[353],"events":[354],"were":[356,366],"fatigue,":[357],"hypertension,":[358],"hand-foot":[359],"syndrome":[360],"(HFS),":[361],"gastrointestinal":[363],"toxicity,":[364],"generally":[367],"manageable":[368],"standard":[370],"medical":[371],"intervention.":[372],"Of":[373],"note,":[374],"incidence":[376],"HFS":[378],"proteinuria":[380],"that":[388],"patients.":[397],"An":[398],"observed":[399],"association":[400],"between":[401],"diastolic":[402],"blood":[403],"pressure":[404],"\u226590":[405],"mmHg":[406],"increased":[408],"suggests":[410],"potential":[411],"use":[412],"as":[413],"prognostic":[415],"biomarker.":[416],"this":[418],"requires":[419],"further":[420],"Two":[422],"randomized":[423],"III":[425],"ongoing":[429],"determine":[431,451],"first-":[442],"second-line":[444],"setting.":[445],"These":[446],"results":[447],"will":[448],"help":[449],"place":[453],"algorithm.":[460]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2093689408","counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":9},{"year":2024,"cited_by_count":16},{"year":2023,"cited_by_count":8},{"year":2022,"cited_by_count":11},{"year":2021,"cited_by_count":17},{"year":2020,"cited_by_count":14},{"year":2019,"cited_by_count":10},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":12},{"year":2016,"cited_by_count":10},{"year":2015,"cited_by_count":17},{"year":2014,"cited_by_count":11},{"year":2013,"cited_by_count":10},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
